NASDAQ:KALV - Kalvista Pharmaceuticals SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
Get Started
$29.47 +1.27 (+4.50 %)
(As of 03/26/2019 01:23 AM ET)
Previous Close$28.20
Today's Range$27.35 - $29.47
52-Week Range$7.73 - $34.92
Volume90,886 shs
Average Volume178,465 shs
Market Capitalization$508.36 million
P/E Ratio-19.26
Dividend YieldN/A
Beta2.45

SEC Filings

Kalvista Pharmaceuticals (NASDAQ:KALV) SEC Filings

DateFilerForm TypeView
03/20/2019
3:43 PM		Kalvista Pharmaceuticals (Subject)
SVLSF IV, LLC (Filed by)
Form SC 13D/A
View Filing
03/20/2019
3:13 PM		Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
03/20/2019
3:08 PM		Kalvista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners II, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings II, LLC (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management II, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
03/15/2019
7:03 PM		Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
03/14/2019
3:52 PM		Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  		View Filing
03/14/2019
3:44 PM		Kalvista Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  		View Filing
03/14/2019
3:16 PM		Kalvista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  		View Filing
03/06/2019
8:05 AM		Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
02/26/2019
7:30 AM		Kalvista Pharmaceuticals (Subject)
SVLSF IV, LLC (Filed by)
Form SC 13D/A
View Filing
02/21/2019
1:35 PM		Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
02/05/2019
4:41 PM		Kalvista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
02/05/2019
4:39 PM		Kalvista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
Form 3
Initial statement of beneficial ownership of securities  		View Filing
02/01/2019
3:30 PM		Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  		View Filing
01/29/2019
5:53 PM		Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
01/24/2019
6:48 PM		Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
01/24/2019
6:44 PM		Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4/A
View Filing
01/18/2019
4:42 PM		Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
01/16/2019
5:25 PM		Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
01/07/2019
4:12 PM		Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
01/02/2019
6:10 PM		Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
12/23/2018
11:16 PM		Kalvista Pharmaceuticals (Filer)
Form EFFECT
View Filing
12/21/2018
3:19 PM		Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
12/14/2018
4:17 PM		Kalvista Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  		View Filing
12/14/2018
3:16 PM		Kalvista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  		View Filing
12/14/2018
6:53 AM		Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  		View Filing
10/05/2018
5:08 PM		Kalvista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
10/05/2018
5:07 PM		Kalvista Pharmaceuticals (Issuer)
ORONSKY ARNOLD L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
10/05/2018
5:05 PM		Cha Albert (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
10/05/2018
5:03 PM		ALDRICH RICHARD (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
10/04/2018
3:00 PM		Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  		View Filing
09/26/2018
3:00 PM		Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  		View Filing
09/20/2018
6:35 PM		Kalvista Pharmaceuticals (Issuer)
Maetzel Andreas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
09/20/2018
6:33 PM		Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
09/20/2018
6:31 PM		Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
09/20/2018
6:29 PM		Kalvista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
09/20/2018
6:26 PM		Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
09/14/2018
3:11 PM		Kalvista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  		View Filing
09/12/2018
6:16 PM		Kalvista Pharmaceuticals (Issuer)
ORONSKY ARNOLD L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
09/12/2018
6:11 PM		Cha Albert (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
09/12/2018
3:32 PM		Kalvista Pharmaceuticals (Subject)
Vivo Ventures VI, LLC (Filed by)
Form SC 13G
View Filing
09/10/2018
3:30 PM		Kalvista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G/A
View Filing
09/10/2018
3:27 PM		Kalvista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners II, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings II, LLC (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management II, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  		View Filing
09/06/2018
8:59 PM		Kalvista Pharmaceuticals (Filer)
Form 424B5
View Filing
09/06/2018
3:02 PM		Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  		View Filing
09/05/2018
4:03 PM		Kalvista Pharmaceuticals (Filer)
Form 424B5
View Filing
08/15/2018
3:10 PM		Kalvista Pharmaceuticals (Filer)
Form DEF 14A
View Filing
08/09/2018
3:33 PM		Kalvista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G
View Filing
08/01/2018
3:59 PM		Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  		View Filing
08/01/2018
3:46 PM		Kalvista Pharmaceuticals (Filer)
Form 424B5
View Filing
07/31/2018
7:30 AM		Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  		View Filing
07/30/2018
4:25 PM		Kalvista Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  		View Filing
07/30/2018
4:20 PM		Kalvista Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  		View Filing
06/06/2018
4:15 PM		Kalvista Pharmaceuticals (Issuer)
Maetzel Andreas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
06/06/2018
4:11 PM		Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
06/06/2018
4:09 PM		Kalvista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
06/06/2018
4:06 PM		Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
06/06/2018
4:02 PM		Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  		View Filing
04/20/2018
3:11 PM		Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  		View Filing
03/16/2018
3:06 PM		Kalvista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  		View Filing
03/16/2018
6:30 AM		Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  		View Filing
03/13/2018
11:10 AM		Kalvista Pharmaceuticals (Filer)
Form CT ORDER
View Filing
02/12/2018
4:20 PM		EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Kalvista Pharmaceuticals (Subject)
Form SC 13G
View Filing
12/14/2017
4:17 PM		Kalvista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  		View Filing
12/14/2017
7:22 AM		Kalvista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  		View Filing
This page was last updated on 3/26/2019 by MarketBeat.com Staff

Featured Article: Why is the Consumer Price Index (CPI) important?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel